CutisCare Appoints Dr. Bob Bartlett to Chief Medical Officer, Strengthening Commitment to Advancing Wound Care Solutions

BOCA RATON, Fla., Feb. 22, 2024 /PRNewswire/ — CūtisCare LLC, a leading provider in wound care and hyperbaric management, proudly announces the promotion of Dr. Bob Bartlett, MD, to the position of Chief Medical Officer (CMO). This strategic move underscores CutisCare’s dedication to delivering unparalleled wound care services and advancing healthcare solutions.

Dr. Bartlett’s journey with CutisCare began when he joined the Medical Advisory Board, bringing with him over 30 years of clinical and corporate expertise in wound healing, hyperbaric therapy, research and knowledge management. (https://www.linkedin.com/in/bobbartlettmd/)

CūtisCare LLC, a leading provider in wound care management, appoints Dr. Bob Bartlett as Chief Medical Officer.

Post this

A Magna cum Laude graduate of the University of South Alabama School of Medicine, Dr. Bartlett holds numerous certifications, including Certified Physician Executive, Certified Wound Specialist, and Hyperbaric Medicine. His impact on the field extends to his recent roles as Chief Medical Officer for Swift Medical and past President of the Board for the Academy of Physicians in Wound Healing.

As a member of CutisCare’s Medical Advisory Board, Dr. Bartlett has played a pivotal role in enhancing education and thought leadership within the company. His commitment to mentorship and disseminating best practices in wound care aligns seamlessly with CutisCare’s mission to be a resource for hospitals and providers, offering the highest quality wound care services through a network of clinics.

Jim Patrick, CutisCare Board Chairman, and CEO expressed enthusiasm about Dr. Bartlett’s promotion, stating, “Dr. Bob Bartlett’s elevation to Chief Medical Officer marks a significant milestone for CutisCare. His wealth of experience and leadership in the wound healing community will contribute to our ongoing commitment to excellence in patient care and clinical research.”

In his new position as CMO, Dr. Bartlett will play a key role in shaping CutisCare’s strategy to design customized outpatient wound care and hyperbaric oxygen solutions for hospitals, academic medical centers, hospital systems and physician practices. This appointment reaffirms CutisCare’s dedication to collaboration, research, and a culture of compliance for providers and patients with chronic wounds.

About CūtisCareHeadquartered in Boca Raton, Florida, CūtisCare works with hospitals, academic medical centers, hospital systems, and physician practices to design customized outpatient wound care and hyperbaric oxygen (HBOT) solutions. With coast-to-coast operations, CūtisCare continues to develop innovative solutions to meet the changing healthcare environment.

For more information, visit https://cutiscareusa.com and follow us CutisCare LLC | LinkedIn.

CONTACT: CūtisCare LLC, Boca Raton
Kelly Caceres, 904-446-0708 (media)
Craig Jenkins, CFO/ COO, 561-617-7059 (others)

SOURCE CutisCare LLC

By signing up you agree to receive content from us.Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber’s engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you’ll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.

Go to Source